Several states investigating CVS Caremark for unfair dealings
New York City Lawmakers, customers, and pharmacists are accusing CVS Caremark of using its combined clout to pressure consumers to use CVS.
According to Fortune magazine, besides an FTC probe, several states are investigating the $99 billion company, which some people hope will be broken up. "I think there's potential for an actual divestiture," says David Balto, a former FTC policy director who now works with the National Community Pharmacists Association.